SEATTLE — Phase Genomics, Inc., a biotech company leading advancements in next-generation sequencing (NGS) solutions for genome assembly and analysis, today announced the launch of its new platform for precision oncology. The OncoTerra platform implements a rapid, cost-effective alternative to current cytogenomic analysis tools while unlocking information in even the most challenging of sample types. […]
Qlucore, provider of intuitive bioinformatics software for research and precision and companion diagnostics, announces the creation of a Scientific Advisory Board (SAB), consisting of five members, chaired by Carl-Johan Ivarsson, CEO of Qlucore. The SAB includes two of Qlucore’s founders; Thoas Fioretos and Magnus Fontes and three independent senior and renowned scientists and industry experts. […]
High Throughput, On-Premises Variant Interpretation Appliance Provides Advanced AI and Data Acceleration Technologies for Genomics Applications Genomenon, Inc.®, an AI-driven genomics company, announced a partnership with OmniTier, which includes integration of the Mastermind® Genomic Search Engine into their on-premises based CompStor Insight® genomics analysis platform. This integration will allow CompStor® users to preview the number of published articles related to their search […]
Version 3.8 of Qlucore Omics Explorer enables faster and improved data visualizations. Qlucore, leading software provider of powerful visualization-based bioinformatics data analysis tools, announces Qlucore Omics Explorer (QOE) version 3.8, with new features that will improve ease of use and enhance performance. Qlucore Omics Explorer is a next-generation bioinformatics software for research in life science, […]
Protein Metrics is market-leading software leveraged by more than 450 scientific enterprises for the large-scale study of proteins San Diego, CA, 21 December 2021: Insightful Science, the software company enabling the Cloud for Scientific Discovery, announced today that it has completed the transaction to acquire Protein Metrics, Inc., a leading provider of biopharmaceutical protein characterization and proteomics analysis software. […]
Company poised to transform personalized drug development and clinical healthcare in 2022, following series of key pharma partnerships leveraging its leading genomics platform and global real-world data access network Latest partnership, with the Colorado Center for Personalised Medicine, could prove pivotal for identifying gene-drugs conflicts in clinical practice BC Platforms (BCP), a global leader in […]
Remix Therapeutics is a Boston-based biotechnology company developing novel small molecule therapies for reprogramming RNA processing and treating disease in entirely new ways. As protein targeting therapies reach the limits of what can be easily druggable, reprogramming RNA processing offers an exciting new therapeutic opportunity. While protein dysfunction is often the direct cause of disease, the […]
Genedata Biologics integrates, automates, and streamlines Ligand Pharmaceuticals’ OmniAb in vivo antibody discovery platform Basel, Switzerland — Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that Ligand Pharmaceuticals (NASDAQ: LGND) has chosen Genedata Biologics® as the global biologics R&D workflow and data management platform for their OmniAb antibody discovery platform. […]
Bellinzona, Switzerland – BigOmics Analytics SA (“BigOmics”), a Swiss biodata analytics startup, announced today that it raised a total of $1.85 million in financing. This funding will allow the company to expand its team and to commercialize its governed self-service analytics (GSSA) platforms to empower life scientists. BigOmics raised $1.42 million on the first closing of […]
Dr. David Ledbetter Named Chief Clinical and Research Officer of UPN BOSTON – Seven Bridges Genomics, the industry-leading bioinformatics ecosystem provider, today announced the formation of a new subsidiary, the Unified Patient Network (UPN), to facilitate clinical research and collaboration between participating health systems and biopharma companies with a focus on advancing precision medicine and improving […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
